KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $232,000 | +14.9% | 39,646 | +4.2% | 0.01% | +50.0% |
| Q3 2016 | $202,000 | -78.6% | 38,043 | -73.3% | 0.00% | -75.0% |
| Q2 2016 | $943,000 | +28.6% | 142,343 | -9.3% | 0.02% | +23.1% |
| Q1 2016 | $733,000 | +218.7% | 157,022 | +245.1% | 0.01% | +550.0% |
| Q4 2015 | $230,000 | -53.2% | 45,500 | -7.4% | 0.00% | -60.0% |
| Q2 2015 | $491,000 | +206.9% | 49,142 | +322.1% | 0.01% | +400.0% |
| Q3 2014 | $160,000 | -86.9% | 11,643 | -85.4% | 0.00% | -83.3% |
| Q2 2014 | $1,224,000 | -53.0% | 79,579 | -48.0% | 0.01% | -57.1% |
| Q1 2014 | $2,606,000 | -45.5% | 152,940 | -58.6% | 0.01% | -44.0% |
| Q4 2013 | $4,783,000 | +66.1% | 369,388 | +29.4% | 0.02% | +38.9% |
| Q3 2013 | $2,879,000 | -49.0% | 285,424 | -62.2% | 0.02% | -47.1% |
| Q2 2013 | $5,647,000 | – | 755,979 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
| Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
| 1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
| Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
| FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
| OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
| Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
| Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
| Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
| THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |